marijuana legalization

5 articles
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Tilray's Low Valuation Masks Deeper Troubles in Booming Cannabis Beverage Market

Tilray trades cheaply in the fast-growing cannabis beverage sector, but persistent losses and weak fundamentals suggest it's a value trap, not a bargain.
TLRYmarket growthmarijuana legalization
The Motley FoolThe Motley Fool··Thomas Niel

Green Thumb Stock Looks Cheap: Licensing Deal Shift Could Unlock 100% Upside

Green Thumb stock fell 10% YTD despite analyst targets doubling current prices. A licensing deal shift to $70M fixed annual fee could significantly boost earnings as revenue expands.
RYMearnings growthcannabis stocks
The Motley FoolThe Motley Fool··Thomas Niel

Canopy Growth's 99.6% Collapse: Structural Decay or Contrarian Opportunity?

Canopy Growth collapsed 99.6% due to persistent losses, regulatory barriers, and cash burn. Analyst recommend stronger alternatives like Green Thumb Industries.
CGCCRONstock declineshareholder dilution
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Tilray Faces Profitability Headwinds Despite Diversification Push

Tilray struggles with profitability despite diversification into hemp and beverages. Acquisition-driven growth caused shareholder dilution and asset write-downs, raising questions about long-term viability.
TLRYprofitability concernsacquisition strategy
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Tilray and Canopy Growth Navigate Evolving Cannabis Market Landscape

Tilray and Canopy Growth strengthen positions amid shifting U.S. cannabis regulations. Both improve financials, with Tilray offering broader geographic diversification versus Canopy's focused approach.
CGCTLRYCanopy Growthcannabis stocks